SEC Form 4 · accession 0001209191-17-026295
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Bonner
Officer — Chief Financial Officer
Period of report
Apr 7, 2017
Accepted (ET)
Apr 7, 2017 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2017 | A | 2,500 | $6.45 | A | 15,300 | D | |
| Common StockF2 | Apr 7, 2017 | F | 653 | $6.45 | D | 14,647 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award will vest 100% on March 17, 2021.
- F2This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 2,000 shares during March 2017.